Synpacts article demonstrates the transformation of bicyclo[1.1.0]butanes into oxygenated compounds, suggesting new avenues for medicinal chemistry.
Bicyclo[1.1.0]butanes (BCBs) are versatile strain-release building blocks, yet their oxygenative transformations remain underdeveloped due to the instability of oxene intermediates. To address this challenge, we recently reported the use of pyridine N-oxide-derived triplet diradicals as stabilized oxene surrogates for BCB oxygenation. This Synpacts article highlights that work, tracing the conceptual foundations in pyridine N-oxide photochemistry and the reaction-design logic of the programmed ring-opening/reclosing sequence that underpins the transformation. The strategy provides efficient access to 5-oxa-2-oxo-bicyclo[2.1.1]hexanes (5-oxa-2-oxo-BCHex) and related oxygenated scaffolds. Notably, the 5-oxa-2-oxo-BCHex motif reproduces the exit vectors of meta-substituted benzenes, highlighting its potential as a three-dimensional bioisostere in medicinal chemistry.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: